COVID-19 Point of Care (POC) Tests - Medical Devices Pipeline Assessment, 2020

COVID-19 Point of Care (POC) Tests - Medical Devices Pipeline Assessment, 2020



This Medical Devices sector report, COVID 19 point of care (POC) Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the COVID 19 point of care (POC) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

COVID 19 Point of Care (POC) Tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the COVID 19 point of care (POC) Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of COVID 19 point of care (POC) Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of COVID 19 point of care (POC) Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date



2 Introduction
2.1 COVID 19 point of care (POC) Tests Overview
3 Products under Development
3.1 COVID 19 point of care (POC) Tests - Pipeline Products by Stage of Development
3.2 COVID 19 point of care (POC) Tests - Pipeline Products by Territory
3.3 COVID 19 point of care (POC) Tests - Pipeline Products by Regulatory Path
3.4 COVID 19 point of care (POC) Tests - Pipeline Products by Estimated Approval Date
3.5 COVID 19 point of care (POC) Tests - Ongoing Clinical Trials
4 COVID 19 point of care (POC) Tests - Pipeline Products under Development by Companies
4.1 COVID 19 point of care (POC) Tests Companies - Pipeline Products by Stage of Development
4.2 COVID 19 point of care (POC) Tests - Pipeline Products by Stage of Development
5 COVID 19 point of care (POC) Tests Companies and Product Overview
5 COVID 19 point of care Companies and Product Overview
6 COVID 19 point of care - Recent Developments
7 Appendix

List Of Tables


Table 1: COVID 19 point of care (POC) Tests - Pipeline Products by Stage of Development
Table 2: COVID 19 point of care (POC) Tests - Pipeline Products by Territory
Table 3: COVID 19 point of care (POC) Tests - Pipeline Products by Regulatory Path
Table 4: COVID 19 point of care (POC) Tests - Pipeline Products by Estimated Approval Date
Table 5: COVID 19 point of care (POC) Tests - Ongoing Clinical Trials
Table 6: COVID 19 point of care (POC) Tests Companies - Pipeline Products by Stage of Development
Table 7: COVID 19 point of care (POC) Tests - Pipeline Products by Stage of Development
Table 8: 20/20 GeneSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: CoronaCheck COVID-19 Rapid Antibody Test Kit - OTC - Product Status
Table 10: CoronaCheck COVID-19 Rapid Antibody Test Kit - OTC - Product Description
Table 11: 3a-Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Microbial-Enzyme Screening Test - COVID-19 - Product Status
Table 13: Microbial-Enzyme Screening Test - COVID-19 - Product Description
Table 14: RT-PCR COVID-19 Test Kit - Product Status
Table 15: RT-PCR COVID-19 Test Kit - Product Description
Table 16: 3M Co Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Rapid COVID-19 Test - Product Status
Table 18: Rapid COVID-19 Test - Product Description
Table 19: Abbott Laboratories Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Panbio COVID-19 IgG/IgM Rapid Test Device - Product Status
Table 21: Panbio COVID-19 IgG/IgM Rapid Test Device - Product Description
Table 22: Abingdon Health Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 23: AbC-19 Rapid Test - Product Status
Table 24: AbC-19 Rapid Test - Product Description
Table 25: QwikZyme - Product Status
Table 26: QwikZyme - Product Description
Table 27: Abnova Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 28: COVID-19 Human IgM/IgG Rapid Test - Product Status
Table 29: COVID-19 Human IgM/IgG Rapid Test - Product Description
Table 30: Lateral Flow Rapid Test - COVID-19 - Product Status
Table 31: Lateral Flow Rapid Test - COVID-19 - Product Description
Table 32: Serum Antibody Rapid Test - COVID-19 - Product Status
Table 33: Serum Antibody Rapid Test - COVID-19 - Product Description
Table 34: Abnova Corp - Ongoing Clinical Trials Overview
Table 35: Serum Antibody Rapid Test - COVID-19 - Study Evaluate the Efficacy of Serum Antibody Rapid Test - COVID-19
Table 36: Absea Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 37: MEGA Test - SARS-CoV-2 - Product Status
Table 38: MEGA Test - SARS-CoV-2 - Product Description
Table 39: Absology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Absoludy COVID-19 IgM/IgG Rapid Test - Product Status
Table 41: Absoludy COVID-19 IgM/IgG Rapid Test - Product Description
Table 42: Academia Sinica Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Anti-SARS-CoV-2 Nucleocapsid Protein Human IgM/IgG Rapid Detection Kit - Product Status
Table 44: Anti-SARS-CoV-2 Nucleocapsid Protein Human IgM/IgG Rapid Detection Kit - Product Description
Table 45: SARS-CoV-2 Nucleocapsid Protein Rapid Detection Kit - Product Status
Table 46: SARS-CoV-2 Nucleocapsid Protein Rapid Detection Kit - Product Description
Table 47: Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Rapid C2T Total Antibodies (IgG/IgM) Card - Product Status
Table 49: Rapid C2T Total Antibodies (IgG/IgM) Card - Product Description
Table 50: Accobiotech Sdn Bhd Pipeline Products & Ongoing Clinical Trials Overview

List Of Figures


Figure 1: COVID 19 point of care (POC) Tests - Pipeline Products by Stage of Development
Figure 2: COVID 19 point of care (POC) Tests - Pipeline Products by Territory
Figure 3: COVID 19 point of care (POC) Tests - Pipeline Products by Regulatory Path
Figure 4: COVID 19 point of care (POC) Tests - Pipeline Products by Estimated Approval Date
Figure 5: COVID 19 point of care (POC) Tests - Ongoing Clinical Trials

Reconstruction Meshes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Reconstruction Meshes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)Reconstruction Meshes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to

USD 7500 View Report

Disposable Endoscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Disposable Endoscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)Disposable Endoscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to

USD 7500 View Report

Global Point of Care (PoC) Lipid Test Market Research Report 2021-2025

POC diagnostic devices are used to obtain diagnostic results while with the patient or close to the patient. In the context of China-US trade war and global economic volatility and

USD 3200 View Report

Global Civil and Defence Helicopter Market (Value, Units) – Analysis By Application Type, Point of Sale (OEM, MRO), Weight, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)

Executive The Global Civil and Defence Helicopter Market, valued at USD 25.2 billion in the year 2020 has been witnessing unprecedented growth in the last few years on the back

USD 2400 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available